MSB 3.42% $1.21 mesoblast limited

teva trying to hide a monster .., page-2

  1. 203 Posts.
    and that's another non Teva version. It is clear that there's a great deal of uncertainty out there re phase 3 and there is absolutely nothing from msb or teva to allay those concerns. Even something as simple as 'teva reconfirms its commitment to the msb phase 3 revascor trials' would suffice. But no - nothing. To suggest that Teva is trying to keep msb quiet? Glaxo etc would be monitoring every move of msb. I must respectfully disagree Vin. IMO, MSB may be great scientists, but they are appalling at investor relations. I hope in time to be proved wrong.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.